AVAH trades at a discount despite growth in payor deals & services. With solid fundamentals amid labor shortages, is it a buy or hold after earnings?

Q4 2024 Management View CEO Jeff Shaner emphasized that Q4 2024 revenue reached approximately $520 million, an 8.6% increase from the previous year, driven by improved payer rates and cost reductions.

This guidance includes the impact of a 53rd week in Q4. Plans for 2025 include enhancing preferred payor partnerships, achieving synergies in Medical Solutions, and maintaining a disciplined focus ...

The lower promoter pledge is expected to enable Aster DM Healthcare to negotiate better terms with its lenders, allowing ...

Precision health leader adds Coriell’s pharmacogenomics capabilities to expand the application of genomics and increase patient access to more personalized and effective health careST. PETERSBURG, Fla ...

Good morning, and welcome to Aveanna Healthcare Holdings Fourth Quarter 2024 Earnings Conference Call. Today's call is being recorded and we have allocated one hour for prepared remarks and Q&A. At ...

Becker’s asked C-suite executives from hospitals and health systems across the U.S. to share their biggest lesson from the ...

Aveanna Healthcare posted Q4 EPS of $0.05, beating forecasts, with revenue up 8.6% to $519.9 million. The company expects ...

The 10-K report also delves into the company's financial performance, highlighting key metrics and financial results.

As soon as the incident was discovered, immediate action was taken to mitigate and remediate the incident and to help prevent ...